Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Aggrecan Neoepitope Antibody - BSA Free, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 19 publications
Supplier: Novus Biologicals NB10074350SS
Description
Aggrecan Neoepitope Polyclonal specifically detects Aggrecan Neoepitope in Human, Mouse, Rat, Porcine, Bovine, Canine samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.Specifications
Aggrecan Neoepitope | |
Polyclonal | |
Unconjugated | |
PBS and 30% Glycerol with 0.1% Sodium Azide | |
AGC1SEDK, aggrecan, aggrecan core protein, Cartilage-specific proteoglycan core protein, Chondroitin sulfate proteoglycan 1, Chondroitin sulfate proteoglycan core protein 1, CSPCP, CSPG1aggrecan 1, CSPGCP, large aggregating proteoglycan, MSK16AGCAN | |
Rabbit | |
61 kDa | |
0.025 mL | |
Cancer, Mesenchymal Stem Cell Markers, Stem Cell Markers | |
176 | |
Human, Mouse, Rat, Pig, Bovine, Canine | |
IgG |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
1 mg/mL | |
Western Blot 1:1000, Flow Cytometry reported in scientific literature (PMID 21482542), Immunohistochemistry 1:1000, Immunocytochemistry/Immunofluorescence 1:20-1:100, Immunohistochemistry-Paraffin 1:1000, Immunohistochemistry-Frozen reported in scientific literature (PMID 21482542) | |
P16112 | |
ACAN | |
A synthetic peptide corresponding to a region of human Aggrecan (within residues 350-400). [UniProt# P16112] | |
Affinity Purified | |
RUO | |
Primary | |
Aggrecan Neo (JSCNIT) | |
Store at -20C. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction